Skip to main content

Miss. Supreme Court Temporarily Halts An Upcoming Talc Trial

Miss. Supreme Court Temporarily Halts An Upcoming Talc Trial

Miss. Supreme Court Temporarily Halts An Upcoming Talc Trial

Introduction

The Missouri Supreme Court passed an order on Monday, January 14, which temporarily paused an upcoming talcum powder trial involving claims filed by 13 women or their spouses, who alleged that Johnson & Johnson's asbestos-contaminated talc caused their ovarian cancer.

The order sustained a petition for a permanent writ of prohibition filed by J&J to stop the trial, which was slated to begin in St. Louis on Tuesday, January 15, and the jury selection for the same was about to begin this week. This was the second ovarian cancer case against J&J comprising of multiple plaintiffs. An earlier multi-plaintiff talc case concluded with a jury award of $4.7 billion granted to 22 women suffering from ovarian cancer. Attorney Beth Bauer wrote in the petition that consolidating too many plaintiffs into a single trial might confuse and mislead the jury in reaching towards an appropriate decision resulting in massive verdict amounts.

More than 1,000 lawsuits are pending against the talc manufacturer, which are centralized for pretrial proceedings in the District of New Jersey, presided over by Hon. Freda L. Wolfson, U.S.D.J./ Hon. Lois H. Goodman, U.S.M.J. as a part of multidistrict litigation (MDL No. 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation).

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!